InvestorsHub Logo
Post# of 253635
Next 10
Followers 839
Posts 120735
Boards Moderated 13
Alias Born 09/05/2002

Re: madrose1 post# 164397

Wednesday, 06/24/2015 8:28:13 AM

Wednesday, June 24, 2015 8:28:13 AM

Post# of 253635
TTHI—Phase-2/3 trial of ELND005 in agitation/aggression of AD fails primary endpoint:

http://finance.yahoo.com/news/transition-therapeutics-announces-results-clinical-100100129.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.